Abstract
Over the past decade, a large number of strategies and technologies have been developed to reduce heart failure progression. Among these, cardiac tissue engineering is one of the most promising. Aim of this study is to develop a 3D scaffold to treat cardiac failure. A new three-block copolymer, obtained from δ-valerolactone and polyoxyethylene, was synthesised under high vacuum without catalyst. Copolymer/gelatine blends were microfabricated to obtain a ECM-like geometry. Structures were studied under morphological, mechanical, degradation and biological aspects. To prevent left ventricular remodelling, constructs were biofunctionalises with molecularly imprinted nanoparticles towards the matrix metalloproteinase MMP-9. Results showed that materials are able to reproduce the ECM structure with high resolution, mechanical properties were in the order of MPa similar to those of the native myocardium and cell viability was verified. Nanoparticles showed the capability to rebind MMP-9 (specific rebinding 18.67) and to be permanently immobilised on the scaffold surface.
Similar content being viewed by others
References
Jawad H, Lyon AR, Harding SE, Ali NN, Boccaccini AR. Myocardial tissue engineering. Br Med Bull. 2008;87:31–47.
Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev. 2003;8:259–69.
Leor J, Amsalem Y, Cohen S. Cells, scaffold, and molecules for myocardial tissue engineering. Pharmacol Ther. 2005;105:151–63.
Prabhakaran MP, Venugopal J, Kai D, Ramakrishna S. Biomimetic material strategies for cardiac tissue engineering. Mater Sci Eng C. 2011;31:503–13.
Giusti P, Lazzeri L, Lelli L. Bioartificial polymeric materials: a new method to design biomaterials by using both biological and synthetic polymers. Trends Polym Sci. 1993;1:261–7.
Cristallini C, Lazzeri L, Cascone MG, Polacco G, Lupinacci D, Barbani N. Enzyme-based bioartificial polymeric materials. The system a-amylase-poly(vinyl alcohol). Polym Int. 1997;44:510–6.
Cristallini C, Barbani N, Giusti P, Lazzeri L, Cascone MG, Ciardelli G. Polymerization onto biological templates, a new way to obtain bioartificial polymeric materials. Macromol Chem Phys. 2001;202:2104–13.
Guerra GD, Cristallini C, Rosellini E, Barbani N. A hydroxyapatite-collagen composite useful to make bioresorbable scaffolds for bone reconstruction. Adv Sci Technol. 2010;76:133–8.
Rosellini E, Cristallini C, Barbani N, Vozzi G, D’Acunto M, Ciardelli G, Giusti P. New bioartificial systems and biodegradable synthetic polymers for cardiac tissue engineering: a preliminary screening. Biomed Eng Appl Basis Commun. 2010;22:497–507.
Mukherjee S, Gualandi C, Focarete ML, Ravichandran R, Venugopal JR, Raghunath M, Ramakrishna S. Elastomeric electrospun scaffolds of poly(l-lactide-co-trimethylene carbonate) for myocardial tissue engineering. J Mater Sci Mater Med. 2011;22:1689–99.
Kai D, Prabhakaran MP, Jin G, Ramakrishna S. Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering. J Biomed Mater Res B Appl Biomater. 2011;98B:379–86.
Tsang VL, Bhatia SN. Three-dimensional tissue fabrication. Adv Drug Deliver Rev. 2004;56:1635–47.
Chen CS, Mrksich M, Huang S, Whitsides GM, Ingber DE. Geometric control of cell life and death. Science. 1997;276:1425–8.
Wang PY, Yu J, Lin JH, Tsai WB. Modulation of alignment, elongation and contraction of cardiomyocytes through a combination of nanotopography and rigidity of substrates. Acta Biomater. 2011. doi:10.1016/j.actbio.2011.05.021.
Yeong WY, Sudarmadji N, Yu HY, Chua CK, Leong KF, Venkatraman SS, Boey YCF, Tan LP. Porous polycaprolactone for cardiac tissue engineering fabricated by selective laser sintering. Acta Biomateralia. 2010;6:2028–34.
Ciardelli G, Chiono V, Cristallini C, Barbani N, Ahluwalia A, Vozzi G, Previti A, Tantussi G, Giusti P. Innovative tissue engineering structures through advanced manufacturing technologies. J Mater Sci Mater Med. 2004;15:305–10.
Rosellini E, Vozzi G, Barbani N, Giusti P, Cristallini C. Three-dimensional microfabricated scaffolds with cardiac extracellular matrix-like architecture. Int J Artif Organs. 2010;33:885–94.
Causa F, Netti PA, Ambrosio L. A multi-functional scaffold for tissue regeneration: the need to engineer a tissue analogue. Biomaterials. 2007;28(34):5093–9.
Khademhosseini A, Langer R. Nanobiotechnology for drug delivery and tissue engineering. Chem Eng Prog. 2006;102:38–42.
Rechichi A, Cristallini C, Vitale U, Ciardelli G, Barbani N, Vozzi G, Giusti P. New biomedical devices with selective peptide recognition properties. Part 1: characterization and cytotoxicity of molecularly imprinted polymers. J Cell Mol Med. 2007;11(6):1367–76.
Mosbach K, Ramström O. The emerging technique of molecular imprinting and its future impact on biotechnology. Biotechnology. 1996;14:163–70.
Shea KJ. Molecular imprinting of synthetic network polymers: the de novo synthesis of macromolecular binding and catalytic sites. Trends Polym Sci. 1994;2:166–73.
Steinke J, Sherrington D, Dunkin I. Imprinting of synthetic polymers using molecular templates. Adv Polym Sci. 1995;123:80–125.
Cristallini C, Ciardelli G, Giusti P, Barbani N. Acrylonitrile–acrylic acid copolymer membrane imprinted with uric acid for clinical uses. Macromol Biosci. 2004;4:31–8.
Ciardelli G, Borrelli C, Silvestri D, Cristallini C, Barbani N, Giusti P. Supported imprinted nanospheres for the selective recognition of cholesterol. Biosensors Bioelectron. 2006;21:2329–38.
Silvestri D, Barbani N, Cristallini C, Giusti P, Ciardelli G. Molecularly imprinted membranes for an improved recognition of biomolecules in aqueous medium. J Membr Sci. 2006;282:284–95.
Rosellini E, Barbani N, Giusti P, Ciardelli G, Cristallini C. Novel bioactive scaffolds with fibronectin recognition nanosites based on molecular imprinting technology. J Appl Polym Sci. 2010;118:3236–44.
Rosellini E, Barbani N, Giusti P, Rechichi A, Cristallini C. Molecularly imprinted nanoparticles with recognition properties towards a laminin H–Tyr–Ile–Gly–Ser–Arg–OH sequence for tissue engineering applications. Biomed Mater. 2010;5:065007.
Cohn D, Younes H. Biodegradable PEO/PLA block copolymers. J Biomed Mater Res. 1988;22:993–1009.
Kimura Y, Matsuzaki Y, Yamame H, Kitao T. Preparation of block copoly(ester-ether) comprising poly(l-lactide) and poly(oxypropylene) and degradation of its fibre in vitro and in vivo. Polymer. 1989;30:1342–9.
Cerrai P, Tricoli M, Andruzzi F, Paci M, Paci M. Synthesis and characterization of polymers from β-propiolactone and poly(ethylene glycol)s. Polymer. 1987;28:831–6.
Cerrai P, Tricoli M, Andruzzi F, Paci M, Paci M. Polyether-polyester block copolymers by non-catalysed polymerization of ε-caprolactone with poly(ethylene glycol). Polymer. 1989;30:338–43.
Cerrai P, Tricoli M. Block copolymers from l-lactide and poly(ethylene glycol) through a non-catalyzed route. Makromol Chem Rapid Commun. 1993;14:529–38.
Sbarbati-Del Guerra R, Cascone MG, Tricoli M, Cerrai P. In vitro validation of poly(ester–ether–ester) block copolymers as biomaterials. Altern Lab Anim. 1993;21:97–101.
Cascone MG, Tricoli M, Cerrai P, Sbarbati Del Guerra R. Cell cultures in the biocompatibility study of synthetic materials. Cytotechnology. 1993;11:S137–9.
Cerrai P, Guerra GD, Lelli L, Tricoli M, Sbarbati Del Guerra R, Cascone MG, Giusti P. Poly(ester–ether–ester) block copolymers as biomaterials. J Mater Sci Mater Med. 1994;5:33–9.
Cerrai P, Tricoli M, Lelli L, Guerra GD, Sbarbati Del Guerra R, Cascone MG, Giusti P. Block copolymers of l-lactide and poly(ethylene glycol) for biomedical applications. J Mater Sci Mater Med. 1994;5:308–13.
Sbarbati Del Guerra R, Cristallini C, Rizzi N, Barsacchi R, Guerra GD, Tricoli M, Cerrai P. The biodegradation of poly(ester–ether–ester) block copolymers in a cellular environment in vitro. J Mater Sci Mater Med. 1994;5:891–5.
Sbarbati Del Guerra R, Gazzetti P, Lazzerini G, Cerrai P, Guerra GD, Tricoli M, Cristallini C. Degradation products of poly(ester–ether–ester) block copolymers do not alter endothelial metabolism in vitro. J Mater Sci Mater Med. 1995;6:824–8.
Cerrai P, Cristallini C, Del Chicca MG, Guerra GD, Maltinti S, Sbarbati Del Guerra R, Tricoli M. Hydrolysis of poly(ester–ether–ester) block copolymers in the presence of endothelial cells: in vitro modulation of endothelin release. Polym Bull. 1997;39:53–8.
Guerra GD, Cristallini C, Barbani N, Gagliardi M. Bioresorbable microspheres as devices for the controlled release of paclitaxel. Int J Biol Biomed Eng. 2011;5:121–8.
Wu J, Zeng F, Huang X-P, Chung JC-Y, Konecny F, Weisel RD, Li R-K. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials. 2011;32:579–86.
Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006;69:604–13.
Krumme D, Wenzel H, Tschesche H. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS Lett. 1998;436:209–12.
Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol. 2006;48:907–13.
Chen Q-Z, Harding SE, Ali NN, Lyon AR, Boccaccini AR. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater Sci Eng R. 2008;59:1–37.
Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascular disease. Circ Res. 2003;92:1068–78.
Agostoni P, Banfi C. Matrix metalloproteinase and heart failure: is it time to move from research to clinical laboratories? Eur Heart J. 2007;28:659–60.
Zeugolis, Zeugolis. The physiological relevance of wet versus dry differential scanning calorimetry for biomaterial evaluation. Polym Int. 2010;59:1403–7.
Mayes AG, Whitcombe MJ. Synthetic strategies for the generation of molecularly imprinted organic polymers. Adv Drug Delivery Rev. 2005;57:1742–78.
Verheyen E, Schillemans JP, van Wijk M, Demeniex M-A, Hennink WE, van Nostrum CF. Challenges for the effective molecular imprinting of proteins. Biomaterials. 2011;32:3008–20.
Squire IB, Evans J, Leong LNG, Loftus IM, Thompson MM. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Cardiac Fail. 2004;10(4):328–33.
Acknowledgments
Authors would acknowledge Dr. F. Boccafoschi (University of Eastern Piedmont “Amedeo Avogadro”, Novara, Italy) for cytotoxicity tests and Dr. T. Prescimone (Institute of Clinical Physiology, National Research Council, Pisa, Italy) for zymography analysis. This work was financially supported by Italian Ministry of University and Research PRIN-2008 grant (Bioartificial stem cell niches for cardiac tissue engineering, 2010–2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cristallini, C., Gagliardi, M., Barbani, N. et al. Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling. J Mater Sci: Mater Med 23, 205–216 (2012). https://doi.org/10.1007/s10856-011-4506-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-011-4506-1